Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

Apr 19, 2022

SELL
$8.43 - $20.9 $87,672 - $217,359
-10,400 Reduced 59.09%
7,200 $66,000
Q4 2021

Jan 28, 2022

BUY
$19.26 - $30.08 $19,260 - $30,080
1,000 Added 6.02%
17,600 $360,000
Q3 2021

Nov 12, 2021

BUY
$24.86 - $35.02 $412,676 - $581,332
16,600 New
16,600 $424,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.